|
US105134A
(en)
*
|
|
1870-07-05 |
|
Thomas sheehan |
|
US32335A
(en)
*
|
|
1861-05-14 |
|
Island |
|
US19535A
(en)
*
|
|
1858-03-02 |
|
Improvement in sewing-machines |
|
US49205A
(en)
*
|
|
1865-08-01 |
|
Improvement in machines for hulling grain |
|
GB589625A
(en)
|
1944-01-19 |
1947-06-25 |
Chem Ind Basel |
Manufacture of new pyridine and piperidine compounds
|
|
US2507631A
(en)
|
1944-01-19 |
1950-05-16 |
Ciba Pharm Prod Inc |
Pyridine and piperidine compounds and process of making same
|
|
GB788226A
(en)
|
1953-12-23 |
1957-12-23 |
Ciba Ltd |
Stereoisomers of ª‡-phenyl-ª‡-piperidyl-(2)-acetic acid and process of making same
|
|
US2838519A
(en)
*
|
1953-12-23 |
1958-06-10 |
Ciba Pharm Prod Inc |
Process for the conversion of stereoisomers
|
|
US2957880A
(en)
|
1953-12-23 |
1960-10-25 |
Ciba Pharm Prod Inc |
Process for the conversion of stereoisomers
|
|
GB878167A
(en)
|
1958-11-17 |
1961-09-27 |
Ciba Ltd |
New acetic acid esters
|
|
SU466229A1
(ru)
|
1973-01-23 |
1975-04-05 |
Всесоюзный научно-исследовательский химико-фармацевтический институт им. С.Орджоникидзе |
Способ получени гидрохлорида метилового эфира трео- -фенил- (пиперидил-2)-уксусной кислоты
|
|
US4137300A
(en)
*
|
1976-08-20 |
1979-01-30 |
Ciba-Geigy Corporation |
Sustained action dosage forms
|
|
US4410700A
(en)
*
|
1980-07-03 |
1983-10-18 |
The United States Of America As Represented By The Department Of Health And Human Services |
Preparation of chiral 1-benzyl-1,2,3,4-tetrahydroisoquinolines by optical resolution
|
|
GB2112730B
(en)
*
|
1981-09-30 |
1985-12-18 |
Nat Res Dev |
Encapsulated particles
|
|
US4904476A
(en)
*
|
1986-03-04 |
1990-02-27 |
American Home Products Corporation |
Formulations providing three distinct releases
|
|
US4794001A
(en)
*
|
1986-03-04 |
1988-12-27 |
American Home Products Corporation |
Formulations providing three distinct releases
|
|
US4986987A
(en)
*
|
1986-05-09 |
1991-01-22 |
Alza Corporation |
Pulsed drug delivery
|
|
US5114946A
(en)
|
1987-06-12 |
1992-05-19 |
American Cyanamid Company |
Transdermal delivery of pharmaceuticals
|
|
US4992445A
(en)
|
1987-06-12 |
1991-02-12 |
American Cyanamid Co. |
Transdermal delivery of pharmaceuticals
|
|
US5236689A
(en)
*
|
1987-06-25 |
1993-08-17 |
Alza Corporation |
Multi-unit delivery system
|
|
US5391381A
(en)
*
|
1987-06-25 |
1995-02-21 |
Alza Corporation |
Dispenser capable of delivering plurality of drug units
|
|
US5283193A
(en)
|
1988-06-27 |
1994-02-01 |
Asahi Kasei Kogyo K.K. |
Process for producing optically active α-substituted organic acid and microorganism and enzyme used therefor
|
|
SE509029C2
(sv)
*
|
1988-08-16 |
1998-11-30 |
Ss Pharmaceutical Co |
Långtidsverkande diklofenak-natriumpreparat
|
|
US5202128A
(en)
*
|
1989-01-06 |
1993-04-13 |
F. H. Faulding & Co. Limited |
Sustained release pharmaceutical composition
|
|
US5133974A
(en)
*
|
1989-05-05 |
1992-07-28 |
Kv Pharmaceutical Company |
Extended release pharmaceutical formulations
|
|
US5217718A
(en)
|
1989-08-18 |
1993-06-08 |
Cygnus Therapeutic Systems |
Method and device for administering dexmedetomidine transdermally
|
|
US5284769A
(en)
|
1989-10-16 |
1994-02-08 |
Chiros Ltd. |
Process for preparing a single enantiomer of a lactam using lactamase
|
|
US5362755A
(en)
|
1990-01-05 |
1994-11-08 |
Sepracor, Inc. |
Method for treating asthma using optically pure (R)-albuterol
|
|
US5229131A
(en)
*
|
1990-02-05 |
1993-07-20 |
University Of Michigan |
Pulsatile drug delivery system
|
|
US5158777A
(en)
*
|
1990-02-16 |
1992-10-27 |
E. R. Squibb & Sons, Inc. |
Captopril formulation providing increased duration of activity
|
|
JP2558396B2
(ja)
*
|
1990-06-28 |
1996-11-27 |
田辺製薬株式会社 |
放出制御型製剤
|
|
US5104899A
(en)
|
1990-08-13 |
1992-04-14 |
Sepracor, Inc. |
Methods and compositions for treating depression using optically pure fluoxetine
|
|
US5232705A
(en)
*
|
1990-08-31 |
1993-08-03 |
Alza Corporation |
Dosage form for time-varying patterns of drug delivery
|
|
US5156850A
(en)
*
|
1990-08-31 |
1992-10-20 |
Alza Corporation |
Dosage form for time-varying patterns of drug delivery
|
|
US5160744A
(en)
*
|
1991-06-27 |
1992-11-03 |
Alza Corporation |
Verapmil therapy
|
|
US5326570A
(en)
*
|
1991-07-23 |
1994-07-05 |
Pharmavene, Inc. |
Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine
|
|
US5593694A
(en)
*
|
1991-10-04 |
1997-01-14 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Sustained release tablet
|
|
DE69222006T2
(de)
*
|
1991-10-30 |
1998-01-22 |
Glaxo Group Ltd |
Mehrschichtzusammensetzungen enthaltend Histamin- oder Serotonin- Antagonisten
|
|
US5478577A
(en)
*
|
1993-11-23 |
1995-12-26 |
Euroceltique, S.A. |
Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
|
|
US5580578A
(en)
*
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
|
US5223265A
(en)
*
|
1992-01-10 |
1993-06-29 |
Alza Corporation |
Osmotic device with delayed activation of drug delivery
|
|
US5308348A
(en)
*
|
1992-02-18 |
1994-05-03 |
Alza Corporation |
Delivery devices with pulsatile effect
|
|
US5331000A
(en)
|
1992-03-09 |
1994-07-19 |
Sepracor Inc. |
Antipyretic and analgesic methods and compositions containing optically pure R(-) ketoprofen
|
|
US5299121A
(en)
*
|
1992-06-04 |
1994-03-29 |
Medscreen, Inc. |
Non-prescription drug medication screening system
|
|
US5512293A
(en)
*
|
1992-07-23 |
1996-04-30 |
Alza Corporation |
Oral sustained release drug delivery device
|
|
DE9320925U1
(de)
|
1992-08-03 |
1995-08-31 |
Georgetown University, Washington, D.C. |
Terfenadin-Metabolite und deren optisch reine Isomere für die Behandlung von allergischen Störungen
|
|
US5376384A
(en)
*
|
1992-12-23 |
1994-12-27 |
Kinaform Technology, Inc. |
Delayed, sustained-release pharmaceutical preparation
|
|
JP3091618B2
(ja)
|
1993-01-29 |
2000-09-25 |
四郎 小林 |
開環重合法および開環重合用酵素触媒
|
|
JP2916978B2
(ja)
*
|
1993-08-25 |
1999-07-05 |
エスエス製薬株式会社 |
放出開始制御型製剤
|
|
US5500227A
(en)
*
|
1993-11-23 |
1996-03-19 |
Euro-Celtique, S.A. |
Immediate release tablet cores of insoluble drugs having sustained-release coating
|
|
US5567441A
(en)
*
|
1995-03-24 |
1996-10-22 |
Andrx Pharmaceuticals Inc. |
Diltiazem controlled release formulation
|
|
IT1276689B1
(it)
|
1995-06-09 |
1997-11-03 |
Applied Pharma Res |
Forma farmaceutica solida ad uso orale
|
|
CA2223629A1
(en)
|
1995-07-14 |
1997-02-06 |
Nicholas Robert Pope |
Therapeutic use of d-threo-methylphenidate
|
|
GB9514451D0
(en)
|
1995-07-14 |
1995-09-13 |
Chiroscience Ltd |
Sustained-release formulation
|
|
WO1997003671A1
(en)
|
1995-07-14 |
1997-02-06 |
Medeva Europe Limited |
Composition comprising d-threo-methylphenidate and another drug
|
|
US5908850A
(en)
|
1995-12-04 |
1999-06-01 |
Celgene Corporation |
Method of treating attention deficit disorders with d-threo methylphenidate
|
|
US5837284A
(en)
|
1995-12-04 |
1998-11-17 |
Mehta; Atul M. |
Delivery of multiple doses of medications
|
|
US5733756A
(en)
|
1996-01-05 |
1998-03-31 |
Celgene Corporation |
Lactams and processes for stereoselective enrichment of lactams, amides, and esters
|
|
US6486177B2
(en)
*
|
1995-12-04 |
2002-11-26 |
Celgene Corporation |
Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
|
|
US5922736A
(en)
*
|
1995-12-04 |
1999-07-13 |
Celegene Corporation |
Chronic, bolus administration of D-threo methylphenidate
|
|
US6355656B1
(en)
*
|
1995-12-04 |
2002-03-12 |
Celgene Corporation |
Phenidate drug formulations having diminished abuse potential
|
|
MX9805870A
(https=)
|
1996-01-22 |
1999-01-31 |
|
|
|
US6242464B1
(en)
*
|
1996-01-22 |
2001-06-05 |
Chiroscience Limited |
Single isomer methylphenidate and resolution process
|
|
JP2000504008A
(ja)
|
1996-02-02 |
2000-04-04 |
メデバ・ユアラプ・リミテッド |
Ｄ―トレオ―（ｒ，ｒ）―メチルフェニデートの調製およびエピメリゼーションによる不要エナンチオマーリサイクルの方法
|
|
GB9604943D0
(en)
*
|
1996-03-08 |
1996-05-08 |
Chiroscience Ltd |
Resolution
|
|
ES2173422T3
(es)
|
1996-03-08 |
2002-10-16 |
Medeva Europ Ltd |
Disociacion de treo-metilfenidato.
|
|
GB9606417D0
(en)
*
|
1996-03-27 |
1996-06-05 |
Chiroscience Ltd |
Asymmetric cyclisation
|
|
ES2264173T3
(es)
|
1996-11-25 |
2006-12-16 |
Alza Corporation |
Forma de dosificacion para suministrar una dosis creciente.
|
|
CZ206299A3
(cs)
|
1996-12-13 |
1999-09-15 |
Medeva Europe Limited |
Způsob přípravy enantiomerně obohaceného THREO-metalfenidátu
|
|
GB9700912D0
(en)
*
|
1997-01-17 |
1997-03-05 |
Chiroscience Ltd |
Resolution
|
|
US5965734A
(en)
*
|
1997-01-31 |
1999-10-12 |
Celgene Corporation |
Processes and intermediates for preparing 2-substituted piperidine stereoisomers
|
|
US6962997B1
(en)
*
|
1997-05-22 |
2005-11-08 |
Celgene Corporation |
Process and intermediates for resolving piperidyl acetamide steroisomers
|
|
US5936091A
(en)
*
|
1997-05-22 |
1999-08-10 |
Celgene Corporation |
Processes and intermediates for resolving piperidyl acetamide stereoisomers
|
|
EP1126826B3
(en)
*
|
1998-11-02 |
2019-05-15 |
Alkermes Pharma Ireland Limited |
Multiparticulate modified release composition of methylphenidate
|
|
US6127385A
(en)
*
|
1999-03-04 |
2000-10-03 |
Pharmaquest Limited |
Method of treating depression using l-threo-methylphenidate
|
|
US6395752B1
(en)
*
|
1999-03-04 |
2002-05-28 |
Pharmaquest Limited |
Method of treating depression using 1-threo-methylphenidate
|
|
GB9913458D0
(en)
|
1999-06-09 |
1999-08-11 |
Medeva Europ Ltd |
The therapeutic use of d-threo-methylphenidate
|
|
AU2199901A
(en)
|
1999-12-17 |
2001-06-25 |
Medeva Europe Limited |
The treatment of convulsive states
|
|
US6221883B1
(en)
*
|
2000-04-12 |
2001-04-24 |
Ross Baldessarini |
Method of dopamine inhibition using l-threo-methylphenidate
|
|
US20020132793A1
(en)
*
|
2000-08-28 |
2002-09-19 |
Mel Epstein |
Use of methylphenidate compounds to enhance memory
|
|
US6344215B1
(en)
*
|
2000-10-27 |
2002-02-05 |
Eurand America, Inc. |
Methylphenidate modified release formulations
|
|
US6359139B1
(en)
*
|
2000-11-07 |
2002-03-19 |
Celgene Corporation |
Methods for production of piperidyl acetamide stereoisomers
|